PROTAC Bcl2 degrader-1
98%
- Product Code: 55747
CAS:
2378801-85-3
| Molecular Weight: | 941.84 g./mol | Molecular Formula: | C₄₅H₄₅BrN₆O₁₀S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
This compound is primarily used in the field of cancer research and therapy. It functions as a Proteolysis Targeting Chimera (PROTAC) designed to target and degrade Bcl-2, a protein that plays a critical role in preventing apoptosis in cancer cells. By degrading Bcl-2, it promotes programmed cell death in malignant cells, making it a promising tool for developing treatments for Bcl-2-dependent cancers such as certain types of leukemia and lymphoma. Its application is particularly significant in overcoming resistance to traditional Bcl-2 inhibitors, offering a novel approach to cancer therapy. Research is ongoing to evaluate its efficacy, specificity, and potential for clinical use.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | Ft579,862.49 |
+
-
|
| 0.005 | 10-20 days | Ft1,045,303.96 |
+
-
|
PROTAC Bcl2 degrader-1
This compound is primarily used in the field of cancer research and therapy. It functions as a Proteolysis Targeting Chimera (PROTAC) designed to target and degrade Bcl-2, a protein that plays a critical role in preventing apoptosis in cancer cells. By degrading Bcl-2, it promotes programmed cell death in malignant cells, making it a promising tool for developing treatments for Bcl-2-dependent cancers such as certain types of leukemia and lymphoma. Its application is particularly significant in overcoming resistance to traditional Bcl-2 inhibitors, offering a novel approach to cancer therapy. Research is ongoing to evaluate its efficacy, specificity, and potential for clinical use.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :